Some new information about the American NIH (National Institute of Health) and a possible Phase II trial have been mentioned in a Swedish newspaper. The information is still very vague with no details released.
It will execute for two years and include 126 patients.
What will differ this trial from the one Diamyd has already made and when it will start is also unclear.
Saturday, April 19, 2008
NIH will conduct a Diamyd Phase II trial
Subscribe to:
Posts (Atom)
Posts
